NKCC(Na-K-Cl 协同转运蛋白)是一种有助于将钠、钾和氯主动转运进出细胞的蛋白质。这种膜转运蛋白有两种,NKCC1 和 NKCC2,但它们由两个不同的基因(分别为 SLC12A2 和 SLC12A1)编码,并且不是同工型。NKCC1/Slc12a2 基因的两种同工型是由保留(同工型 1)或跳过(同工型 2)最终基因产物中的外显子 21 产生的。NKCC1 广泛分布于全身;它在分泌液体的器官中发挥着重要作用。NKCC2 专门存在于肾脏中,它的作用是从尿液中提取钠、钾和氯,以便它们可以被重新吸收到血液中。NKCC 蛋白是膜转运蛋白,可将钠 (Na)、钾 (K) 和氯 (Cl) 离子转运到细胞膜上。由于它们将每种溶质朝同一方向移动,因此 NKCC 蛋白被认为是同向转运蛋白。
NKCC (Na-K-Cl cotransporter) is a protein that aids in the active transport of sodium, potassium, and chloride into and out of cells. There are two varieties of this membrane transport protein, NKCC1 and NKCC2, however these are encoded by two different genes (SLC12A2 and SLC12A1 respectively) and are not isoforms. Two isoforms of the NKCC1/Slc12a2 gene result from keeping (isoform 1) or skipping (isoform 2) exon 21 in the final gene product. NKCC1 is widely distributed throughout the body; it has important functions in organs that secrete fluids. NKCC2 is found specifically in the kidney, where it serves to extract sodium, potassium, and chloride from the urine so that they can be reabsorbed into the blood. NKCC proteins are membrane transport proteins that transport sodium (Na), potassium (K), and chloride (Cl) ions across the cell membrane. Because they move each solute in the same direction, NKCC proteins are considered symporters.
CAII-IN-12 (compound 6c) 是一种高效且选择性的碳酸酐酶 (CA) II 和 VII 抑制剂 (hCA II Ki = 47.8 nM,hCA VII Ki = 3.6 nM),具有抗癫痫活性,对 hCA I 具有选择性 (Ki = 370 nM),在 Pentylenetetrazol 和 Pilocarpine (MS-U99376) 诱导的小鼠癫痫模型中均表现出强效的抗惊厥活性,可增加海马体中 KCC2 的表达,维持神经元完整性,并降低 mTOR 活性,可用于癫痫研究。
CAII/VII-IN-1 是一种口服活性的 hCA II(KI = 12.3 nM)和 hCA VII(KI = 22.6 nM)抑制剂,对 hCA I 无明显活性,在体内 Pilocarpine (MS-U99376) 诱发的癫痫模型中表现出优异的神经保护活性,其机制为上调 KCC2 并抑制 mTOR,且未表现出任何明显的神经毒性作用或肝肾功能改变,因此可用于癫痫的研究。
KCC2 potentiators-1(Compound 2)是一种氯化钾共转运体-2(KCC2)增强剂,有望用于神经系统疾病的研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号